The triad of diabetes mellitus, anemia, and chronic kidney disease (CKD) define a group of patients at high risk for death and cardiovascular complications. The approval of epoetin alfa in 1989 transformed the treatment of anemia in patients with CKD. However, evidence has emerged from randomized...
Partial correction of anemia in patients with chronic kidney disease (CKD) improves anemia-related symptoms. H... JML Gómez,F Carrera - 《Kidney International》 被引量: 85发表: 2002年 Use of the glycemic index for weight loss and glycemic control: a review of recent evidence. This article ...
However, among patients with high bleeding risk, the percentage of individuals for which OAC use was recommended was significantly lower. Indeed, in the present study, previous intracranial or gastrointestinal bleeding and specific risk bleeding factors such as cancer, anemia, and hospitalization due ...
Furthermore, the high prevalence of hyperhomocysteinemia in patients with CKD has increased interest in speculating the role for hyperhomocysteinemia as a risk factor for the progression of CKD [13,14]. The role of folic acid and vitamin B12 role is well recognized, as they are not only ...
CKD comprises a range of diseases and disorders that damage the kidneys and limit their ability to filter body waste. This leads to a serious buildup of toxins in the body, including ammonia, which causes urine-scented breath. Other health complications that can result from CKD include anemia,...